The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis

NCT ID: NCT00503698

Last Updated: 2017-03-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

712 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-31

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is conducted in Africa, Asia, Europe, North and South America and Oceania.

The aim of the trial is to evaluate the effect of somatropin (human growth hormone) on survival (primary end-point; "time to death" and health related quality of life in adult patients on chronic haemodialysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The decision to discontinue the trial is not due to safety concerns. The discontinuation is based on an analysis of the significant delay in recruitment of patients which is expected to have a negative impact on the outcome of the trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Disease End-Stage Renal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Somatropin

Somatropin once daily from week 0 to end of trial

Group Type EXPERIMENTAL

somatropin

Intervention Type DRUG

20 mcg/kg/day, injected s.c. (under the skin)

Placebo

Placebo once daily to end of trial

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DRUG

Placebo injected s.c (under the skin)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

somatropin

20 mcg/kg/day, injected s.c. (under the skin)

Intervention Type DRUG

placebo

Placebo injected s.c (under the skin)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Serum albumin as specified in protocol
* Malnourished (based on serum albumin value below 40 g/L, assessed centrally)
* Stable (for 3 months or more) and adequate haemodialysis treatment three months prior to enrolment as defined by Kt/V of more than 1.2

Exclusion Criteria

* Active malignant disease
* Critical illness requiring treatment in an intensive care unit (ICU)
* Uncontrolled treated/untreated hypertension
* Patients on chronic (more than 3 months) treatment with steroids in doses of more than 10 mg/day prednisolone (or equivalent)
* Patients treated with immunosuppressive agents
* Known Growth Hormone Deficiency
* Patients suffering from any clinically significant disease history in the opinion of the investigator
* Severe illness as defined in the protocol (as judged by the investigator)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Novo Nordisk A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Global Clinical Registry (GCR, 1452)

Role: STUDY_DIRECTOR

Novo Nordisk A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Novo Nordisk Investigational Site

Alexander City, Alabama, United States

Site Status

Novo Nordisk Investigational Site

Birmingham, Alabama, United States

Site Status

Novo Nordisk Investigational Site

Madison, Alabama, United States

Site Status

Novo Nordisk Investigational Site

Mobile, Alabama, United States

Site Status

Novo Nordisk Investigational Site

Mobile, Alabama, United States

Site Status

Novo Nordisk Investigational Site

Montgomery, Alabama, United States

Site Status

Novo Nordisk Investigational Site

Glendale, Arizona, United States

Site Status

Novo Nordisk Investigational Site

Phoenix, Arizona, United States

Site Status

Novo Nordisk Investigational Site

Tempe, Arizona, United States

Site Status

Novo Nordisk Investigational Site

Tucson, Arizona, United States

Site Status

Novo Nordisk Investigational Site

Tuscon, Arizona, United States

Site Status

Novo Nordisk Investigational Site

El Dorado, Arkansas, United States

Site Status

Novo Nordisk Investigational Site

Fort Smith, Arkansas, United States

Site Status

Novo Nordisk Investigational Site

Hot Springs, Arkansas, United States

Site Status

Novo Nordisk Investigational Site

Little Rock, Arkansas, United States

Site Status

Novo Nordisk Investigational Site

McGehee, Arkansas, United States

Site Status

Novo Nordisk Investigational Site

Paragould, Arkansas, United States

Site Status

Novo Nordisk Investigational Site

Pine Bluff, Arkansas, United States

Site Status

Novo Nordisk Investigational Site

Beverly Hills, California, United States

Site Status

Novo Nordisk Investigational Site

Chula Vista, California, United States

Site Status

Novo Nordisk Investigational Site

Covina, California, United States

Site Status

Novo Nordisk Investigational Site

Escondido, California, United States

Site Status

Novo Nordisk Investigational Site

Glendale, California, United States

Site Status

Novo Nordisk Investigational Site

La Mesa, California, United States

Site Status

Novo Nordisk Investigational Site

Lakewood, California, United States

Site Status

Novo Nordisk Investigational Site

Long Beach, California, United States

Site Status

Novo Nordisk Investigational Site

Los Alamitos, California, United States

Site Status

Novo Nordisk Investigational Site

Los Angeles, California, United States

Site Status

Novo Nordisk Investigational Site

Los Angeles, California, United States

Site Status

Novo Nordisk Investigational Site

Los Angeles, California, United States

Site Status

Novo Nordisk Investigational Site

Lynwood, California, United States

Site Status

Novo Nordisk Investigational Site

Merced, California, United States

Site Status

Novo Nordisk Investigational Site

Mission Hills, California, United States

Site Status

Novo Nordisk Investigational Site

Monterey Park, California, United States

Site Status

Novo Nordisk Investigational Site

Mountain View, California, United States

Site Status

Novo Nordisk Investigational Site

Pasadena, California, United States

Site Status

Novo Nordisk Investigational Site

Porterville, California, United States

Site Status

Novo Nordisk Investigational Site

Riverside, California, United States

Site Status

Novo Nordisk Investigational Site

Sacramento, California, United States

Site Status

Novo Nordisk Investigational Site

Torrance, California, United States

Site Status

Novo Nordisk Investigational Site

Vacaville, California, United States

Site Status

Novo Nordisk Investigational Site

Visalia, California, United States

Site Status

Novo Nordisk Investigational Site

Walnut Creek, California, United States

Site Status

Novo Nordisk Investigational Site

Whittier, California, United States

Site Status

Novo Nordisk Investigational Site

Whittier, California, United States

Site Status

Novo Nordisk Investigational Site

Yuba City, California, United States

Site Status

Novo Nordisk Investigational Site

Colorado Springs, Colorado, United States

Site Status

Novo Nordisk Investigational Site

Denver, Colorado, United States

Site Status

Novo Nordisk Investigational Site

Lakewood, Colorado, United States

Site Status

Novo Nordisk Investigational Site

Middlebury, Connecticut, United States

Site Status

Novo Nordisk Investigational Site

Stamford, Connecticut, United States

Site Status

Novo Nordisk Investigational Site

Washington D.C., District of Columbia, United States

Site Status

Novo Nordisk Investigational Site

Atlantis, Florida, United States

Site Status

Novo Nordisk Investigational Site

Brandon, Florida, United States

Site Status

Novo Nordisk Investigational Site

Coral Springs, Florida, United States

Site Status

Novo Nordisk Investigational Site

Jacksonville, Florida, United States

Site Status

Novo Nordisk Investigational Site

Miami, Florida, United States

Site Status

Novo Nordisk Investigational Site

Naples, Florida, United States

Site Status

Novo Nordisk Investigational Site

Orlando, Florida, United States

Site Status

Novo Nordisk Investigational Site

Orlando, Florida, United States

Site Status

Novo Nordisk Investigational Site

Panama City, Florida, United States

Site Status

Novo Nordisk Investigational Site

Pembroke Pines, Florida, United States

Site Status

Novo Nordisk Investigational Site

Tampa, Florida, United States

Site Status

Novo Nordisk Investigational Site

Tampa, Florida, United States

Site Status

Novo Nordisk Investigational Site

Weston, Florida, United States

Site Status

Novo Nordisk Investigational Site

Zephyrhills, Florida, United States

Site Status

Novo Nordisk Investigational Site

Atlanta, Georgia, United States

Site Status

Novo Nordisk Investigational Site

Atlanta, Georgia, United States

Site Status

Novo Nordisk Investigational Site

Augusta, Georgia, United States

Site Status

Novo Nordisk Investigational Site

Augusta, Georgia, United States

Site Status

Novo Nordisk Investigational Site

Macon, Georgia, United States

Site Status

Novo Nordisk Investigational Site

Marietta, Georgia, United States

Site Status

Novo Nordisk Investigational Site

Boise, Idaho, United States

Site Status

Novo Nordisk Investigational Site

Meridian, Idaho, United States

Site Status

Novo Nordisk Investigational Site

Crestwood, Illinois, United States

Site Status

Novo Nordisk Investigational Site

Evergreen Park, Illinois, United States

Site Status

Novo Nordisk Investigational Site

Gurnee, Illinois, United States

Site Status

Novo Nordisk Investigational Site

Maywood, Illinois, United States

Site Status

Novo Nordisk Investigational Site

Evansville, Indiana, United States

Site Status

Novo Nordisk Investigational Site

Indianapolis, Indiana, United States

Site Status

Novo Nordisk Investigational Site

Michigan City, Indiana, United States

Site Status

Novo Nordisk Investigational Site

Des Moines, Iowa, United States

Site Status

Novo Nordisk Investigational Site

Kansas City, Kansas, United States

Site Status

Novo Nordisk Investigational Site

Topeka, Kansas, United States

Site Status

Novo Nordisk Investigational Site

Wichita, Kansas, United States

Site Status

Novo Nordisk Investigational Site

Lexington, Kentucky, United States

Site Status

Novo Nordisk Investigational Site

Madisonville, Kentucky, United States

Site Status

Novo Nordisk Investigational Site

Baton Rouge, Louisiana, United States

Site Status

Novo Nordisk Investigational Site

Lafayatte, Louisiana, United States

Site Status

Novo Nordisk Investigational Site

New Iberia, Louisiana, United States

Site Status

Novo Nordisk Investigational Site

New Orleans, Louisiana, United States

Site Status

Novo Nordisk Investigational Site

New Orleans, Louisiana, United States

Site Status

Novo Nordisk Investigational Site

New Orleans, Louisiana, United States

Site Status

Novo Nordisk Investigational Site

Shreveport, Louisiana, United States

Site Status

Novo Nordisk Investigational Site

Bethesda, Maryland, United States

Site Status

Novo Nordisk Investigational Site

Easton, Maryland, United States

Site Status

Novo Nordisk Investigational Site

Hagerstown, Maryland, United States

Site Status

Novo Nordisk Investigational Site

Rockville, Maryland, United States

Site Status

Novo Nordisk Investigational Site

Silver Spring, Maryland, United States

Site Status

Novo Nordisk Investigational Site

Boston, Massachusetts, United States

Site Status

Novo Nordisk Investigational Site

Brockton, Massachusetts, United States

Site Status

Novo Nordisk Investigational Site

Springfield, Massachusetts, United States

Site Status

Novo Nordisk Investigational Site

Dearborn, Michigan, United States

Site Status

Novo Nordisk Investigational Site

Detroit, Michigan, United States

Site Status

Novo Nordisk Investigational Site

Detroit, Michigan, United States

Site Status

Novo Nordisk Investigational Site

Kalamazoo, Michigan, United States

Site Status

Novo Nordisk Investigational Site

Lansing, Michigan, United States

Site Status

Novo Nordisk Investigational Site

Minneapolis, Minnesota, United States

Site Status

Novo Nordisk Investigational Site

Columbus, Mississippi, United States

Site Status

Novo Nordisk Investigational Site

Gulfport, Mississippi, United States

Site Status

Novo Nordisk Investigational Site

Jackson, Mississippi, United States

Site Status

Novo Nordisk Investigational Site

City of Saint Peters, Missouri, United States

Site Status

Novo Nordisk Investigational Site

Saint Ann, Missouri, United States

Site Status

Novo Nordisk Investigational Site

St Louis, Missouri, United States

Site Status

Novo Nordisk Investigational Site

St Louis, Missouri, United States

Site Status

Novo Nordisk Investigational Site

Billings, Montana, United States

Site Status

Novo Nordisk Investigational Site

Kearney, Nebraska, United States

Site Status

Novo Nordisk Investigational Site

North Platte, Nebraska, United States

Site Status

Novo Nordisk Investigational Site

Eatontown, New Jersey, United States

Site Status

Novo Nordisk Investigational Site

Livingston, New Jersey, United States

Site Status

Novo Nordisk Investigational Site

Voorhees Township, New Jersey, United States

Site Status

Novo Nordisk Investigational Site

Albuquerque, New Mexico, United States

Site Status

Novo Nordisk Investigational Site

Brooklyn, New York, United States

Site Status

Novo Nordisk Investigational Site

Brooklyn, New York, United States

Site Status

Novo Nordisk Investigational Site

Buffalo, New York, United States

Site Status

Novo Nordisk Investigational Site

Buffalo, New York, United States

Site Status

Novo Nordisk Investigational Site

Cooperstown, New York, United States

Site Status

Novo Nordisk Investigational Site

Fresh Meadows, New York, United States

Site Status

Novo Nordisk Investigational Site

Mineola, New York, United States

Site Status

Novo Nordisk Investigational Site

New York, New York, United States

Site Status

Novo Nordisk Investigational Site

New York, New York, United States

Site Status

Novo Nordisk Investigational Site

New York, New York, United States

Site Status

Novo Nordisk Investigational Site

Port Washington, New York, United States

Site Status

Novo Nordisk Investigational Site

Rochester, New York, United States

Site Status

Novo Nordisk Investigational Site

Rosedale, New York, United States

Site Status

Novo Nordisk Investigational Site

The Bronx, New York, United States

Site Status

Novo Nordisk Investigational Site

The Bronx, New York, United States

Site Status

Novo Nordisk Investigational Site

Yonkers, New York, United States

Site Status

Novo Nordisk Investigational Site

Durham, North Carolina, United States

Site Status

Novo Nordisk Investigational Site

Greenville, North Carolina, United States

Site Status

Novo Nordisk Investigational Site

Hamlet, North Carolina, United States

Site Status

Novo Nordisk Investigational Site

Wilmington, North Carolina, United States

Site Status

Novo Nordisk Investigational Site

Winston-Salem, North Carolina, United States

Site Status

Novo Nordisk Investigational Site

Cleveland, Ohio, United States

Site Status

Novo Nordisk Investigational Site

Columbus, Ohio, United States

Site Status

Novo Nordisk Investigational Site

Dayton, Ohio, United States

Site Status

Novo Nordisk Investigational Site

Toledo, Ohio, United States

Site Status

Novo Nordisk Investigational Site

Xenia, Ohio, United States

Site Status

Novo Nordisk Investigational Site

Bend, Oregon, United States

Site Status

Novo Nordisk Investigational Site

Medford, Oregon, United States

Site Status

Novo Nordisk Investigational Site

Roseburg, Oregon, United States

Site Status

Novo Nordisk Investigational Site

Allentown, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Johnstown, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Lewistown, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Meadville, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Philadelphia, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Philadelphia, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Philadelphia, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Pittsburgh, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Pittsburgh, Pennsylvania, United States

Site Status

Novo Nordisk Investigational Site

Providence, Rhode Island, United States

Site Status

Novo Nordisk Investigational Site

Charleston, South Carolina, United States

Site Status

Novo Nordisk Investigational Site

Columbia, South Carolina, United States

Site Status

Novo Nordisk Investigational Site

North Charleston, South Carolina, United States

Site Status

Novo Nordisk Investigational Site

Orangeburg, South Carolina, United States

Site Status

Novo Nordisk Investigational Site

Santee, South Carolina, United States

Site Status

Novo Nordisk Investigational Site

Sumter, South Carolina, United States

Site Status

Novo Nordisk Investigational Site

Sioux Falls, South Dakota, United States

Site Status

Novo Nordisk Investigational Site

Clarksville, Tennessee, United States

Site Status

Novo Nordisk Investigational Site

Dyersburg, Tennessee, United States

Site Status

Novo Nordisk Investigational Site

Knoxville, Tennessee, United States

Site Status

Novo Nordisk Investigational Site

Knoxville, Tennessee, United States

Site Status

Novo Nordisk Investigational Site

Nashville, Tennessee, United States

Site Status

Novo Nordisk Investigational Site

Nashville, Tennessee, United States

Site Status

Novo Nordisk Investigational Site

Nashville, Tennessee, United States

Site Status

Novo Nordisk Investigational Site

Arlington, Texas, United States

Site Status

Novo Nordisk Investigational Site

Corpus Christi, Texas, United States

Site Status

Novo Nordisk Investigational Site

Corpus Christi, Texas, United States

Site Status

Novo Nordisk Investigational Site

Dallas, Texas, United States

Site Status

Novo Nordisk Investigational Site

Dallas, Texas, United States

Site Status

Novo Nordisk Investigational Site

Houston, Texas, United States

Site Status

Novo Nordisk Investigational Site

Houston, Texas, United States

Site Status

Novo Nordisk Investigational Site

Houston, Texas, United States

Site Status

Novo Nordisk Investigational Site

Houston, Texas, United States

Site Status

Novo Nordisk Investigational Site

Killeen, Texas, United States

Site Status

Novo Nordisk Investigational Site

Lubbock, Texas, United States

Site Status

Novo Nordisk Investigational Site

McAllen, Texas, United States

Site Status

Novo Nordisk Investigational Site

San Antonio, Texas, United States

Site Status

Novo Nordisk Investigational Site

San Antonio, Texas, United States

Site Status

Novo Nordisk Investigational Site

Tyler, Texas, United States

Site Status

Novo Nordisk Investigational Site

Weslaco, Texas, United States

Site Status

Novo Nordisk Investigational Site

Provo, Utah, United States

Site Status

Novo Nordisk Investigational Site

Burlington, Vermont, United States

Site Status

Novo Nordisk Investigational Site

Alexandria, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Charlottesville, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Chesapeake, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Fairfax, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Hampton, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Mechanicsville, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Norfolk, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Portsmouth, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Salem, Virginia, United States

Site Status

Novo Nordisk Investigational Site

Seattle, Washington, United States

Site Status

Novo Nordisk Investigational Site

Bluefield, West Virginia, United States

Site Status

Novo Nordisk Investigational Site

Glendale, Wisconsin, United States

Site Status

Novo Nordisk Investigational Site

Marshfield, Wisconsin, United States

Site Status

Novo Nordisk Investigational Site

Milwaukee, Wisconsin, United States

Site Status

Novo Nordisk Investigational Site

Neenah, Wisconsin, United States

Site Status

Novo Nordisk Investigational Site

Oshkosh, Wisconsin, United States

Site Status

Novo Nordisk Investigational Site

Buenos Aires, , Argentina

Site Status

Novo Nordisk Investigational Site

Buenos Aires, , Argentina

Site Status

Novo Nordisk Investigational Site

Capital Federal, , Argentina

Site Status

Novo Nordisk Investigational Site

Capital Federal, , Argentina

Site Status

Novo Nordisk Investigational Site

Córdoba, , Argentina

Site Status

Novo Nordisk Investigational Site

Morón, , Argentina

Site Status

Novo Nordisk Investigational Site

Pergamino, , Argentina

Site Status

Novo Nordisk Investigational Site

San Miguel de Tucumán, , Argentina

Site Status

Novo Nordisk Investigational Site

Sarandí, , Argentina

Site Status

Novo Nordisk Investigational Site

Temperley, , Argentina

Site Status

Novo Nordisk Investigational Site

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Novo Nordisk Investigational Site

Curitiba, , Brazil

Site Status

Novo Nordisk Investigational Site

Fortaleza, , Brazil

Site Status

Novo Nordisk Investigational Site

Fortaleza, , Brazil

Site Status

Novo Nordisk Investigational Site

Jaboatao de Guararapes, , Brazil

Site Status

Novo Nordisk Investigational Site

Porto Alegre, , Brazil

Site Status

Novo Nordisk Investigational Site

Porto Alegre, , Brazil

Site Status

Novo Nordisk Investigational Site

Porto Alegre, , Brazil

Site Status

Novo Nordisk Investigational Site

São José Rio Preto, , Brazil

Site Status

Novo Nordisk Investigational Site

São Paulo, , Brazil

Site Status

Novo Nordisk Investigational Site

Sorocaba, , Brazil

Site Status

Novo Nordisk Investigational Site

Edmonton, Alberta, Canada

Site Status

Novo Nordisk Investigational Site

Halifax, Nova Scotia, Canada

Site Status

Novo Nordisk Investigational Site

Toronto, Ontario, Canada

Site Status

Novo Nordisk Investigational Site

Montreal, Quebec, Canada

Site Status

Novo Nordisk Investigational Site

Greenfield Park, , Canada

Site Status

Novo Nordisk Investigational Site

London, , Canada

Site Status

Novo Nordisk Investigational Site

Peterborough, , Canada

Site Status

Novo Nordisk Investigational Site

Regina, , Canada

Site Status

Novo Nordisk Investigational Site

Saskatoon, , Canada

Site Status

Novo Nordisk Investigational Site

Scarborough, , Canada

Site Status

Novo Nordisk Investigational Site

Thunder Bay, , Canada

Site Status

Novo Nordisk Investigational Site

Beijing, Beijing Municipality, China

Site Status

Novo Nordisk Investigational Site

Beijing, Beijing Municipality, China

Site Status

Novo Nordisk Investigational Site

Nanjing, Jiangsu, China

Site Status

Novo Nordisk Investigational Site

Shanghai, Shanghai Municipality, China

Site Status

Novo Nordisk Investigational Site

Aalborg, , Denmark

Site Status

Novo Nordisk Investigational Site

Arhus N, , Denmark

Site Status

Novo Nordisk Investigational Site

Copenhagen, , Denmark

Site Status

Novo Nordisk Investigational Site

Herlev, , Denmark

Site Status

Novo Nordisk Investigational Site

Hilleroed, , Denmark

Site Status

Novo Nordisk Investigational Site

Holbæk, , Denmark

Site Status

Novo Nordisk Investigational Site

Odense, , Denmark

Site Status

Novo Nordisk Investigational Site

Béziers, , France

Site Status

Novo Nordisk Investigational Site

Bordeaux, , France

Site Status

Novo Nordisk Investigational Site

Bordeaux, , France

Site Status

Novo Nordisk Investigational Site

Cherbourt-Octeville, , France

Site Status

Novo Nordisk Investigational Site

Clermont-Ferrand, , France

Site Status

Novo Nordisk Investigational Site

Dunkirk, , France

Site Status

Novo Nordisk Investigational Site

Lyon, , France

Site Status

Novo Nordisk Investigational Site

Montpellier, , France

Site Status

Novo Nordisk Investigational Site

Muret, , France

Site Status

Novo Nordisk Investigational Site

Nantes, , France

Site Status

Novo Nordisk Investigational Site

Paris, , France

Site Status

Novo Nordisk Investigational Site

Paris, , France

Site Status

Novo Nordisk Investigational Site

Paris, , France

Site Status

Novo Nordisk Investigational Site

Paris, , France

Site Status

Novo Nordisk Investigational Site

Poissy, , France

Site Status

Novo Nordisk Investigational Site

Trappes, , France

Site Status

Novo Nordisk Investigational Site

Vichy, , France

Site Status

Novo Nordisk Investigational Site

Aschaffenburg, , Germany

Site Status

Novo Nordisk Investigational Site

Bad Mergentheim, , Germany

Site Status

Novo Nordisk Investigational Site

Bamberg, , Germany

Site Status

Novo Nordisk Investigational Site

Berlin, , Germany

Site Status

Novo Nordisk Investigational Site

Bernkastel-Kues, , Germany

Site Status

Novo Nordisk Investigational Site

Bottrop, , Germany

Site Status

Novo Nordisk Investigational Site

Dormagen, , Germany

Site Status

Novo Nordisk Investigational Site

Düsseldorf, , Germany

Site Status

Novo Nordisk Investigational Site

Elsenfeld, , Germany

Site Status

Novo Nordisk Investigational Site

Fürstenzell, , Germany

Site Status

Novo Nordisk Investigational Site

Gütersloh, , Germany

Site Status

Novo Nordisk Investigational Site

Hamburg, , Germany

Site Status

Novo Nordisk Investigational Site

Hamburg, , Germany

Site Status

Novo Nordisk Investigational Site

Hanover, , Germany

Site Status

Novo Nordisk Investigational Site

Heilbronn, , Germany

Site Status

Novo Nordisk Investigational Site

Kiel, , Germany

Site Status

Novo Nordisk Investigational Site

Krefeld, , Germany

Site Status

Novo Nordisk Investigational Site

Limburg an der Lahn, , Germany

Site Status

Novo Nordisk Investigational Site

Lüdenscheid, , Germany

Site Status

Novo Nordisk Investigational Site

Mettmann, , Germany

Site Status

Novo Nordisk Investigational Site

Minden, , Germany

Site Status

Novo Nordisk Investigational Site

Nettetal, , Germany

Site Status

Novo Nordisk Investigational Site

Passau, , Germany

Site Status

Novo Nordisk Investigational Site

Schweinfurt, , Germany

Site Status

Novo Nordisk Investigational Site

Straubing, , Germany

Site Status

Novo Nordisk Investigational Site

Würzburg, , Germany

Site Status

Novo Nordisk Investigational Site

Würzburg, , Germany

Site Status

Novo Nordisk Investigational Site

Budapest, , Hungary

Site Status

Novo Nordisk Investigational Site

Budapest, , Hungary

Site Status

Novo Nordisk Investigational Site

Eger, , Hungary

Site Status

Novo Nordisk Investigational Site

Kecskemét, , Hungary

Site Status

Novo Nordisk Investigational Site

Sopron, , Hungary

Site Status

Novo Nordisk Investigational Site

Hyderabad, Andhra Pradesh, India

Site Status

Novo Nordisk Investigational Site

Hyderabad, , India

Site Status

Novo Nordisk Investigational Site

Pune, , India

Site Status

Novo Nordisk Investigational Site

Ashkelon, , Israel

Site Status

Novo Nordisk Investigational Site

Hadera, , Israel

Site Status

Novo Nordisk Investigational Site

Haifa, , Israel

Site Status

Novo Nordisk Investigational Site

Jerusalem, , Israel

Site Status

Novo Nordisk Investigational Site

Petah Tikva, , Israel

Site Status

Novo Nordisk Investigational Site

Rehovot, , Israel

Site Status

Novo Nordisk Investigational Site

Tzriffin, , Israel

Site Status

Novo Nordisk Investigational Site

Bologna, , Italy

Site Status

Novo Nordisk Investigational Site

Brescia, , Italy

Site Status

Novo Nordisk Investigational Site

Genova, , Italy

Site Status

Novo Nordisk Investigational Site

Milan, , Italy

Site Status

Novo Nordisk Investigational Site

Modena, , Italy

Site Status

Novo Nordisk Investigational Site

Pavia, , Italy

Site Status

Novo Nordisk Investigational Site

Krakow, , Poland

Site Status

Novo Nordisk Investigational Site

Kraśnik, , Poland

Site Status

Novo Nordisk Investigational Site

Kwidzyn, , Poland

Site Status

Novo Nordisk Investigational Site

Myślenice, , Poland

Site Status

Novo Nordisk Investigational Site

Ostrów Mazowiecka, , Poland

Site Status

Novo Nordisk Investigational Site

Poznann, , Poland

Site Status

Novo Nordisk Investigational Site

Puławy, , Poland

Site Status

Novo Nordisk Investigational Site

Radom, , Poland

Site Status

Novo Nordisk Investigational Site

Sieradz, , Poland

Site Status

Novo Nordisk Investigational Site

Sochaczew, , Poland

Site Status

Novo Nordisk Investigational Site

Słupca, , Poland

Site Status

Novo Nordisk Investigational Site

Ul Mlynska 5, , Poland

Site Status

Novo Nordisk Investigational Site

Wejherowo, , Poland

Site Status

Novo Nordisk Investigational Site

Wroclaw, , Poland

Site Status

Novo Nordisk Investigational Site

Abrantes, , Portugal

Site Status

Novo Nordisk Investigational Site

Amadora, , Portugal

Site Status

Novo Nordisk Investigational Site

Braga, , Portugal

Site Status

Novo Nordisk Investigational Site

Corroios, , Portugal

Site Status

Novo Nordisk Investigational Site

Entroncamento, , Portugal

Site Status

Novo Nordisk Investigational Site

Evora, , Portugal

Site Status

Novo Nordisk Investigational Site

Setúbal, , Portugal

Site Status

Novo Nordisk Investigational Site

Torres Vedras, , Portugal

Site Status

Novo Nordisk Investigational Site

Villa Franca de Xira, , Portugal

Site Status

Novo Nordisk Investigational Site

Villa Nova de Gaia, , Portugal

Site Status

Novo Nordisk Investigational Site

Ponce, , Puerto Rico

Site Status

Novo Nordisk Investigational Site

Moscow, , Russia

Site Status

Novo Nordisk Investigational Site

Moscow, , Russia

Site Status

Novo Nordisk Investigational Site

Petrozavodsk, , Russia

Site Status

Novo Nordisk Investigational Site

Saint Petersburg, , Russia

Site Status

Novo Nordisk Investigational Site

Saint Petersburg, , Russia

Site Status

Novo Nordisk Investigational Site

Saint Petersburg, , Russia

Site Status

Novo Nordisk Investigational Site

Saint Petersburg, , Russia

Site Status

Novo Nordisk Investigational Site

Saint Petersburg, , Russia

Site Status

Novo Nordisk Investigational Site

Johannesburg, Gauteng, South Africa

Site Status

Novo Nordisk Investigational Site

Obervatory, , South Africa

Site Status

Novo Nordisk Investigational Site

Barcelona, , Spain

Site Status

Novo Nordisk Investigational Site

Burgos, , Spain

Site Status

Novo Nordisk Investigational Site

Córdoba, , Spain

Site Status

Novo Nordisk Investigational Site

Granollers, , Spain

Site Status

Novo Nordisk Investigational Site

Madrid, , Spain

Site Status

Novo Nordisk Investigational Site

Santander, , Spain

Site Status

Novo Nordisk Investigational Site

Seville, , Spain

Site Status

Novo Nordisk Investigational Site

Valencia, , Spain

Site Status

Novo Nordisk Investigational Site

Stockholm, , Sweden

Site Status

Novo Nordisk Investigational Site

Uppsala, , Sweden

Site Status

Novo Nordisk Investigational Site

Värnamo, , Sweden

Site Status

Novo Nordisk Investigational Site

Ankara, , Turkey (Türkiye)

Site Status

Novo Nordisk Investigational Site

Istanbul, , Turkey (Türkiye)

Site Status

Novo Nordisk Investigational Site

Istanbul, , Turkey (Türkiye)

Site Status

Novo Nordisk Investigational Site

Istanbul, , Turkey (Türkiye)

Site Status

Novo Nordisk Investigational Site

Aberdeen, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Birmingham, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Cambridge, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Coventry, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Glasgow, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Leicester, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Liverpool, , United Kingdom

Site Status

Novo Nordisk Investigational Site

London, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Londonderry, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Manchester, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Rhyl, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Sheffield, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Swansea, , United Kingdom

Site Status

Novo Nordisk Investigational Site

Wolverhampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Brazil Canada China Denmark France Germany Hungary India Israel Italy Poland Portugal Puerto Rico Russia South Africa Spain Sweden Turkey (Türkiye) United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Kopple JD, Cheung AK, Christiansen JS, Djurhuus CB, El Nahas M, Feldt-Rasmussen B, Lange M, Mitch WE, Wanner C, Wiedemann J, Ikizler TA. OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol. 2008 Nov;3(6):1741-51. doi: 10.2215/CJN.02760608.

Reference Type RESULT
PMID: 18945992 (View on PubMed)

Raff AC, Meyer TW, Hostetter TH. New insights into uremic toxicity. Curr Opin Nephrol Hypertens. 2008 Nov;17(6):560-5. doi: 10.1097/MNH.0b013e32830f45b6.

Reference Type RESULT
PMID: 18941347 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://novonordisk-trials.com

Clinical Trials at Novo Nordisk

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2006-004702-56

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

NN1630-1453

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.